Related Experiment Video
Updated: Mar 6, 2026
Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts
Published on: May 16, 2020
Third and fourth branchial cleft cysts - A 25-year institutional experience of imaging detection and pathologic
Saeed Rahmani1, Irene Dixe de Oliveira Santo2, Joseph Kim3
1Tu Lab for Diagnostic Research, Yale School of Medicine, New Haven, CT, USA; Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Background And Purpose:
Third and fourth branchial cleft cysts (BCCs) are rare and often mimic other lower-neck cystic lesions. Tract conspicuity is frequently limited on single-time-point imaging, particularly during inflammation. We report a 25-year institutional experience evaluating Proportion Undergoing Surgery and Pathology-Confirmed BCC Rate.
Materials And Methods:
We retrospectively queried radiology reports (January 2000-December 2024) to identify suspected third and fourth BCCs. Reports and images were reviewed to classify lesions; pathology was cross-referenced for operated cases. Outcomes were (1) Proportion Undergoing Surgery rate (operated/total) by modality and clinical setting and (2) Pathology-Confirmed BCC Rate (PPV for any BCC among operated) overall, by modality, and by imaging category (3rd, 4th, 3rd vs 4th). Exact (Clopper-Pearson) 95% CIs were calculated. An exploratory logistic regression among operated patients evaluated predictors of Pathology-Confirmed BCC. Analyses used IBM SPSS Statistics 27.0.
Results:
Fifty-two patients met inclusion criteria (US 34.6%, CT 50.0%, MR 15.4%). Distribution by setting was 73.1% outpatient, 11.5% inpatient, and 15.4% emergency department. Overall, 24/52 (46.2%) underwent surgery. Proportion Undergoing Surgery rates by modality were 44.4% (US), 46.2% (CT), 50.0% (MR). Proportion Undergoing Surgery by setting was 42.1% (outpatient), 33.3% (inpatient), 75.0% (ED). Among operated patients, pathology confirmed BCC in 5/24 (PPV 20.8%; 95% CI, 7.1-42.2). PPV by modality: 50.0% (US), 8.3% (CT), 0.0% (MR). PPV by imaging category: 9.1% (3rd), 25.0% (4th), 40.0% ("3rd vs 4th"). No covariate was a significant predictor of pathologic confirmation in exploratory modeling; some parameters were not estimatable due to sparse cells.
Conclusions:
Third and fourth BCCs are rare. Fewer than half of suspected third and fourth BCCs on imaging were operated on - only a minority of these were pathologically confirmed. Imaging alone seems unlikely to be able to distinguish between third and fourth BCCs or to delineate these lesions from similar cystic abnormalities in the neck.
Related Concept Videos
01:22Imaging Studies VI: Voiding Cystourethrography and Cystography
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
01:20Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
01:20Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...